Stochter
Profile Picture
European Investor 23 Jun 2026, 14:34
IBM (NYSE: IBM) climbed 4.2% after receiving a series of positive analyst actions, highlighted by JPMorgan upgrading the stock to Overweight from Neutral and raising its price target to $291 from $270. RBC Capital also reiterated its Outperform rating, while Morgan Stanley established a $267 price target.

The strong move comes as investors continue to favor software and enterprise technology companies with meaningful exposure to artificial intelligence. IBM has increasingly positioned itself as a beneficiary of growing AI adoption through its watsonx platform, consulting business, and hybrid cloud offerings.

Unlike many semiconductor stocks that faced pressure during Tuesday's technology selloff, IBM attracted investor interest as a more defensive AI play with recurring software and services revenue. The company is also benefiting from growing demand for enterprise AI solutions as organizations look to deploy generative AI applications across their operations.

The analyst upgrades suggest Wall Street sees further upside in IBM's AI strategy and its ability to convert growing demand into revenue growth. The stock's gain reflects increasing confidence that IBM can benefit from the AI investment cycle while offering a more stable earnings profile than many higher-growth technology companies.

Comments

No comments yet.